Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Wave Life Sciences (WVE) has a market cap of $0.96 billion USD. According to our data, Wave Life Sciences is ranked No.5093 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.96 B |
-48.91%
|
| Dec 31, 2024 | $1.89 B |
144.95%
|
| Dec 29, 2023 | $0.77 B |
-27.86%
|
| Dec 30, 2022 | $1.07 B |
122.93%
|
| Dec 31, 2021 | $0.48 B |
-60.10%
|
| Dec 31, 2020 | $1.20 B |
-1.87%
|
| Dec 31, 2019 | $1.22 B |
-80.92%
|
| Dec 31, 2018 | $6.41 B |
19.77%
|
| Dec 29, 2017 | $5.35 B |
34.23%
|
| Dec 30, 2016 | $3.99 B |
63.95%
|
| Dec 31, 2015 | $2.43 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
USA
|
 Moderna
MRNA
|
$10.14 B |
-0.001 M
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
| Market Cap | = | WVE Stock Price | * | WVE Shares Outstanding |
| = | $6.28 | * | 0.15 B | |
| = | $0.96 B |